Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Authors:
- 1 June 1997
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (6) , 691-705
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.Radiology, 1995
- Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.Radiology, 1993
- Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve.Radiology, 1993
- Recurrent rectal cancer and scar: differentiation with PET and MR imaging.Radiology, 1992
- Recurrence of colorectal tumors: PET evaluation.Radiology, 1989
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Positron emission tomography in Alzheimer's diseaseNeurology, 1986
- Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]DeoxyglucoseJournal of Cerebral Blood Flow & Metabolism, 1985
- Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.Radiology, 1982